 |
最寄りの施設や診療機関を探してください。
※2008/12/31現在、
掲載数3,976件
|
|
|
|
|
骨・骨粗鬆症 > [連載]転倒予防と骨粗鬆症(3) 骨粗鬆症ガイドラインと転倒予防／薬物治療のエビデンス 文献
|
|
骨粗鬆症ガイドラインと転倒予防／薬物治療のエビデンス 文献
１）折茂肇ほか：骨粗鬆症の治療（薬物療法）に関するガイドライン―２００２年度改訂版―．Osteoporos Jpn 10：635-709, 2002.
２）鈴木隆雄ほか：地域高齢者の転倒発生に関連する身体的要因の分析的研究：５年間の追跡研究から．日老医誌．1999；36：472-478.
３）Province MA, Hadly EC, Hornbrook MC, Lipsitz LA, Miller JP, et al. The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. JAMA 273：1341-1347, 1995.
４）Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE, Cumming RG, Rowe BH. Interventions for preventing falls in elderly people. Cochrane Database Sys Rev 3* CD000340, 2001.
５）Robertson MC, Campbell AJ, Gardner MM, Devlin N. Preventing injuries in older people by preventing falls：a meta-analysis of individual-level data. J Am Geriatr Soc 50：905-911, 2002.
６）Chang JT, Morton SC, Rubenstein LZ, Mojica WA, Maglione M, Suttorp MJ. Intervention for the prevention of falls in older adults：systematic review and meta-analysis of randomised clinical trials. BMJ 328：680, 2004.
７）Weatherall M. Prevention of falls and fall-related fractures in community-dwelling older adults：a meta-analysis of estimates of effectiveness based on recent guidelines. Int Med J 34：102-108. 2004.
８）Cranny A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C, The osteoporosis methodology group and the osteoprosis research adivisory group. Summary of meta-analysis of therapies for postmenopausal osteoporosis. Endocr Rev 2002；23：570-578.
９）Recker R, Hinders S, Davies M et al. Correvting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 1996；11：1961-1966.
10）Shea B, Wells G, Cranny A, Zytaruk N, Robinson V et al. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 2002；23：552-559.
11）Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention nonvertebral fractures：a meta-analysis of randomized trials. JAMA 2001；285：2891-2897.
12）Wells G, Tugwell P, Cranny A, Shea B, Guyatt G et al. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 2002；23：529-539.
13）Rossouw JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women：principal results from the Womenユs Health Initiative randomized controlled trial. JAMA 2002；288：321-333.
14）Chesnut III CH, Silverman S, Andriano K, Genant H, Giomona A, Harris S, Kiel D, et al. A randomized trial of nasal spray salmon calcitonin in postimenopausal women with established osteoporosis：the prevent reccurence of osteoporotic fractures study. PROOF study group. Am J Med 2000；109：267-276.
15）Cranny A, Tugwell P , Zytaruk N, Robinson V, et al. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev 2002；23：540-551.
16）Landin-Wilhelmsen K, Wilhelmsen L, Bengtsson BA. Postmenopausal osteoporosis is more related to hormonal aberration than to lifestyle factors. Clin Endocrnol 1999；51：387-394.
17）Orimo H, Shiraki M, Hayashi Y, et al. Effect of 1α-hydroxy vitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994；54：370-376.
18）Tilyard MW, Spears GF, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Eng J Med 1992；326：357-362.
19）Papadimitropoulos E, Wells G, Shea B, Gillespie W, et al. Meta-analysis of efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 2002；23：560-569.
20）Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2（menatetrenone）effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res. 2000；15：515-521.
21）藤田拓男、折茂肇、井上哲郎ほか．退行期骨粗鬆症に対するアルファカルシドールを対照としたエチドロン酸二ナトリウム（EHDP）の二重盲検比較試験．Clin Eval 1993；21：261-302.
22）Cranny A, et al. A meta^analysis of etidoronate for the treatment of postmenopausal osteoporosis. Osteoporos Int 2001；12：140-151.
23）Cranny A, Wells G, Willan A, Groffith L, et al. Meta-analysis of alendoronate for the treatment of postmenopausal women. Endocr Rev 2002；23：508-516.
24）Cranny A, Tugwell P, Adachi J, Weaver B, et al. Meta-analysis of risedoronate for the treatment of postmenopausal osteoporosis. Endocr Rev 2002；23：517-523.
25）McLung MR, Guesens P, Miller PD, et al. Effect of risedoronate on the risk of hip fracture in elderly women. N Eng J Med 2000；343：333-340.
26）Cranny A, Tugwell P, Zytaruk N, Robinson V, et al. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev 2002；23：524-528.
戻る
|
|
